Antidepressant-like effects of the active acidic polysaccharide portion of ginseng in mice

Journal of Ethnopharmacology

Volumn 132, Issue 1, 2010, Pages 65-69

  Wang, Jia ^a   Flaisher Grinberg, Shlomit ^b   Li, Shanshan ^a   Liu, Haibo ^a   Sun, Lin ^a   Zhou, Yifa ^a   Einat, Haim ^b,c  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF MINNESOTA   (United States)

^c TEL HAI COLLEGE   (Israel)

Author keywords

Affective disorders; Animal models; Depression; Ginsenoside; Natural products; Polysaccharide

Indexed keywords

GALACTURONIC ACID; GINSENG EXTRACT; HOMOGALACTURONAN; PECTIN; RHAMNOGALACTURONAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; FORCED SWIMMING TEST; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; MALE; MAZE LEARNING; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PANAX; PECTINS; PLANT EXTRACTS; PLANT ROOTS; SOCIAL BEHAVIOR; SWIMMING;

ANIMALIA; MUS; PANAX GINSENG;

EID: 77957800157     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.07.042     Document Type: Article

References (39)

1. Blumenkrantz N., Asboe-Hansen G. New method for quantitative determination of uronic acids. Analytical Biochemistry 1973, 54:484-489.
2. Carr M.N., Bekku N., Yoshimura H. Identification of anxiolytic ingredients in ginseng root using the elevated plus-maze test in mice. European Journal of Pharmacology 2006, 531:160-165. (Epub 2006 January 2018).
3. Cleary C., Linde J.A., Hiscock K.M., Hadas I., Belmaker R.H., Agam G., Flaisher-Grinberg S., Einat H. Antidepressive-like effects of rapamycin in animal models: implications for mTOR inhibition as a new target for treatment of affective disorders. Brain Research Bulletin 2008, 76:469-473. (Epub 2008 April 2003).
4. Coccaro E.F., Lee R.J., Kavoussi R.J. A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. Journal of Clinical Psychiatry 2009, 70:653-662.
5. Crawley J.N What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice 2000, Wiley-Liss, New York.
6. Cryan J.F., Page M.E., Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl.) 2005, 182:335-344. (Epub 2005 October 2019).
7. Dang H., Chen Y., Liu X., Wang Q., Wang L., Jia W., Wang Y. Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33:1417-1424. (Epub 2009 July 1424).
8. Dubois M., Gilles K.A., Hamilton J.F., REbers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Analytical Chemistry 1956, 28:350-356.
9. Duman R.S. Synaptic plasticity and mood disorders. Molecular Psychiatry 2002, 7:S29-S34.
10. Einat H. Chronic oral administration of ginseng extract results in behavioral change but has no effects in mice models of affective and anxiety disorders. Phytotherapy Research 2007, 21:62-66.
11. Einat H. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Behavior Genetics 2007, 37:244-255.
12. Flaisher-Grinberg S., Einat H. Mice models for the manic pole of bipolar disorder. Mice Models for Mood and Anxiety Disorders 2009, 297-326. Springer Press, Berlin. T.D. Gould (Ed.).
13. Flaisher-Grinberg S., Einat H. Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine. Frontiers in Psychopharmacology 2010, 1.
14. Fugh-Berman A., Cott J.M. Dietary supplements and natural products as psychotherapeutic agents. Psychosomatic Medicine 1999, 61:712-728.
15. Griebel G., Moreau J.L., Jenck F., Misslin R., Martin J.R. Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology (Berl.) 1994, 113:463-470.
16. Ji Y.C., Kim Y.B., Park S.W., Hwang S.N., Min B.K., Hong H.J., Kwon J.T., Suk J.S. Neuroprotective effect of ginseng total saponins in experimental traumatic brain injury. Journal of Korean Medical Science 2005, 20:291-296.
17. Kim D.H., Moon Y.S., Jung J.S., Min S.K., Son B.K., Suh H.W., Song D.K. Effects of ginseng saponin administered intraperitoneally on the hypothalamo-pituitary-adrenal axis in mice. Neuroscience Letters 2003, 343:62-66.
18. Lee E.H., Cho S.Y., Kim S.J., Shin E.S., Chang H.K., Kim D.H., Yeom M.H., Woe K.S., Lee J., Sim Y.C., Lee T.R. Ginsenoside F1 protects human HaCaT keratinocytes from ultraviolet-B-induced apoptosis by maintaining constant levels of Bcl-2. Journal of Investigational Dermatology 2003, 121:607-613.
19. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nature Medicine 2001, 7:541-547.
20. Orsetti M., Colella L., Dellarole A., Canonico P.L., Ferri S., Ghi P. Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats. International Journal of Neuropsychopharmacology 2006, 9:427-436.
21. Park E.K., Choo M.K., Oh J.K., Ryu J.H., Kim D.H. Ginsenoside Rh2 reduces ischemic brain injury in rats. Biological and Pharmacological Bulletin 2004, 27:433-436.
22. Park J.H., Cha H.Y., Seo J.J., Hong J.T., Han K., Oh K.W. Anxiolytic-like effects of ginseng in the elevated plus-maze model: comparison of red ginseng and sun ginseng. Progress in Neuropsychopharmacology and Biological Psychiatry 2005, 29:895-900.
23. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Archives of International Pharmacodyn Therapy 1977, 229:327-336.
24. Radad K., Gille G., Moldzio R., Saito H., Ishige K., Rausch W.D. Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells. Journal of Neural Transmission 2004, 111:37-45. (Epub 2003 December 2003).
25. Radad K., Gille G., Moldzio R., Saito H., Rausch W.D. Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Research 2004, 1021:41-53.
26. Rudakewich M., Ba F., Benishin C.G. Neurotrophic and neuroprotective actions of ginsenosides Rb(1) and Rg(1). Planta Medica 2001, 67:533-537.
27. Salim K.N., McEwen B.S., Chao H.M. Ginsenoside Rb1 regulates ChAT, NGF and trkA mRNA expression in the rat brain. Brain Research Molecular Brain Research 1997, 47:177-182.
28. Sanchez C., Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?. Psychopharmacology (Berl.) 1997, 129:197-205.
29. Savag M.G., Lackman D.B., Smolens J. The isolation of the components of streptococcal nucleoproteins in serologically active form. Journal of Biological Chemistry 1938, 124:425-436.
30. Thommessen B., Laake K. No identifiable effect of ginseng (Gericomplex) as an adjuvant in the treatment of geriatric patients. Aging (Milano) 1996, 8:417-420.
31. Van Kampen J., Robertson H., Hagg T., Drobitch R. Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Experimental Neurology 2003, 184:521-529.
32. Wang L.C., Lee T.F. Effect of ginseng saponins on exercise performance in non-trained rats. Planta Medica 1998, 64:130-133.
33. Wiklund I.K., Mattsson L.A., Lindgren R., Limoni C. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. International Journal of Clinical Pharmacology Research 1999, 19:89-99.
34. Wu C.F., Liu Y.L., Song M., Liu W., Wang J.H., Li X., Yang J.Y. Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice. Pharmacology, Biochemistry, and Behavior 2003, 76:103-109.
35. Xu H., Steven Richardson J., Li X.M. Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 2003, 28:53-62.
36. Yoshimura H., Watanabe K., Ogawa N. Psychotropic effects of ginseng saponins on agonistic behavior between resident and intruder mice. European Journal of Pharmacology 1988, 146:291-297.
37. Zhang X., Yu L., Bi H., Li X., Ni W., Han H., Li N., Wang B., Zhou Y., Tai G. Total fractionation and characterization of the water-soluble polysaccharides isolated from Panax ginseng C.A. Meyer. Carbohydrate Polymers 2009, 77:544.
38. Zhao H., Li Q., Pei X., Zhang Z., Yang R., Wang J., Li Y. Long-term ginsenoside administration prevents memory impairment in aged C57BL/6J mice by up-regulating the synaptic plasticity-related proteins in hippocampus. Behavioural Brain Research 2009, 201:311-317. (Epub 2009 March 2017).
39. Zhu Y., Pettolino F., Mau S.L., Shen Y.C., Chen C.F., Kuo Y.C., Bacic A. Immunoactive polysaccharide-rich fractions from Panax notoginseng. Planta Medica 2006, 72:1193-1199. (Epub 2006 September 1118).